{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:59:33Z","timestamp":1791313173381,"version":"4.3.1"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.3233\/jad-190305","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T14:31:52Z","timestamp":1567780312000},"page":"1187-1199","source":"Crossref","is-referenced-by-count":8,"title":["A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"71","author":[{"given":"Shunichi","family":"Yokoyama","sequence":"first","affiliation":[{"name":"Division of Neurosurgery, Nanpuh Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Yoshinaga","sequence":"additional","affiliation":[{"name":"Division of Clinical Application, Nanpuh Hospital, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntaro","family":"Matsuzaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokai University School of Medicine, Isehara, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190305_ref1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-190305_ref2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/gast.1996.v111.pm8690199","article-title":"Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa","volume":"111","author":"Hirakawa","year":"1996","journal-title":"Gastroenterology"},{"key":"10.3233\/JAD-190305_ref3","doi-asserted-by":"crossref","first-page":"19705","DOI":"10.1074\/jbc.M109.006817","article-title":"A role for HSP70 in protecting against indomethacin-induced gastric lesions","volume":"284","author":"Suemasu","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-190305_ref4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.109.152181","article-title":"HSP70 confers protection against indomethacin-induced lesions of the small intestine","volume":"330","author":"Asano","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-190305_ref5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000236032","article-title":"Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: A prospective randomized placebo-controlled double-blind cross-over study","volume":"80","author":"Niwa","year":"2009","journal-title":"Digestion"},{"key":"10.3233\/JAD-190305_ref6","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.5478-10.2011","article-title":"Suppression of Alzheimer\u2019s disease-related phenotypes by expression of heat shock protein 70 in mice","volume":"31","author":"Hoshino","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-190305_ref7","doi-asserted-by":"crossref","first-page":"e76306","DOI":"10.1371\/journal.pone.0076306","article-title":"Suppression of Alzheimer\u2019s disease-related phenotypes by geranylgeranylacetone in mice","volume":"8","author":"Hoshino","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190305_ref8","unstructured":"American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC."},{"key":"10.3233\/JAD-190305_ref9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-190305_ref10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S1041610292001157","article-title":"Functional assessment staging (FAST) in Alzheimer\u2019s disease: Reliability, validity, and ordinality","volume":"1","author":"Sclan","year":"1992","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-190305_ref11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.64.5.588","article-title":"CLOX: An executive clock drawing task","volume":"64","author":"Royall","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190305_ref12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: A preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-190305_ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1440-1819.1997.tb03199.x","article-title":"Reliability and validity of the Japanese version of the Zarit Caregiver Burden interview","volume":"51","author":"Arai","year":"1997","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-190305_ref14","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.3233\/JAD-190305_ref15","first-page":"448","article-title":"The Alzheimer\u2019s disease assessment scale: An instrument for assessing treatment efficacy","volume":"19","author":"Mohs","year":"1983","journal-title":"Psychopharmacol Bull"},{"key":"10.3233\/JAD-190305_ref16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neulet.2005.03.038","article-title":"Voxel-based morphometry to discriminate early Alzheimer\u2019s disease from controls","volume":"382","author":"Hirata","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-190305_ref17","first-page":"731","article-title":"Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography","volume":"28","author":"Matsuda","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JAD-190305_ref18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneur.58.3.427","article-title":"Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","volume":"58","author":"Doody","year":"2001","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-190305_ref19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0924-977X(00)00067-5","article-title":"Long-term efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease: Final analysis of a US multicentre open-label study","volume":"10","author":"Rogers","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3233\/JAD-190305_ref20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","article-title":"Risk factors for Alzheimer\u2019s disease: A prospective analysis from the Canadian Study of Health and Aging","volume":"156","author":"Lindsay","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-190305_ref21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: The Hisayama study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-190305_ref22","doi-asserted-by":"crossref","first-page":"e38268","DOI":"10.1371\/journal.pone.0038268","article-title":"Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190305_ref23","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-190305_ref24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-190305_ref25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-190305_ref26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.3233\/JAD-190305_ref27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/cdd.2008.172","article-title":"Astroglia in dementia and Alzheimer\u2019s disease","volume":"16","author":"Rodr\u00edguez","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.3233\/JAD-190305_ref28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","article-title":"TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice","volume":"7","author":"Wyss-Coray","year":"2001","journal-title":"Nat Med"},{"key":"10.3233\/JAD-190305_ref29","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199911253412207","article-title":"Treatment of Alzheimer\u2019s disease","volume":"341","author":"Mayeux","year":"1999","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-190305_ref30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-014-0083-0","article-title":"Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled, confirmatory phase III trial","volume":"7","author":"Ikeda","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190305_ref31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/0149-2918(95)80070-0","article-title":"Clinical evaluation of teprenone, a mucosal protective agent, in the treatment of patients with gastric ulcers: A nationwide, multicenter clinical study","volume":"17","author":"Shirakabe","year":"1995","journal-title":"Clin Ther"},{"key":"10.3233\/JAD-190305_ref32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000110654","article-title":"Comparison of the effectiveness of geranylgeranylacetone with cimetidine in gastritis patients with dyspeptic symptoms and gastric lesions: A randomized, double-blind trial in Japan","volume":"75","author":"Sakamoto","year":"2007","journal-title":"Digestion"},{"key":"10.3233\/JAD-190305_ref33","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/ncomms3686","article-title":"Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease","volume":"4","author":"Tanaka","year":"2013","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-190305_ref34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.24125","article-title":"Mild to moderate Alzheimer dementia with insufficient neuropathological changes","volume":"75","author":"Serrano-Pozo","year":"2014","journal-title":"Ann Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:06:43Z","timestamp":1777370803000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":34,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190305","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}